Clinical Study of VG161 in Advanced Intrahepatic Cholangiocarcinoma

Clinical trial NCT06746480 · RECRUITING

Trial details

NCT number: NCT06746480
Sponsor: CNBG-Virogin Biotech (Shanghai) Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Intrahepatic Cholangiocarcinoma

Start date: 2022-03-19
Primary completion: 2025-09-30
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.